Education
About Us
Working with TipRanks
Follow Us
Jung Choi Insider Profile
4 Followers
Jung Choi, Chief Business and Strategy Officer at Global Blood Therapeutics, holds 33.00K shares in Annexon Biosciences (Ticker: ANNX), holds 251.67K shares in Global Blood Therapeutics (Ticker: GBT). Most recently, Jung Choi Bought ― shares of Annexon Biosciences on Dec 03, 2025 for an estimated value of $138.27K.
Jung Choi Global Blood Therapeutics (GBT)Chief Business and Strategy Officer
Global Blood Therapeutics (GBT)
Chief Business and Strategy Officer
Ranked #61,407 out of 105,077 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-9.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Jung Choi holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jung Choi
Jung Choi's Trading History
Global Blood Therapeutics
Mar 03, 2021
―
Uninformative Buy
5.07K
$17.24M
Annexon Biosciences
Dec 03, 2025
Director
Informative Buy
138.27K
$152.13K
List of latest transactions for each holding click on a transaction to see Jung Choi's performance on stock
You May Also Like
Jung Choi insider profile FAQ
What is the percentage of profitable transactions made by Jung Choi?
The percentage of profitable transactions made by Jung Choi is 50%.
What is the average return per transaction made by Jung Choi?
The average return per transaction made by Jung Choi is -9.50%.
What stocks does Jung Choi hold?
Jung Choi holds: GBT, ANNX stocks.
What was Jung Choi’s latest transaction?
Jung Choi latest transaction was an Informative Buy of $138.27K.
What was Jung Choi's most profitable transaction?
Jung Choi’s most profitable transaction was an Informative Buy of ANNX stock on December 3, 2025. The return on the trade was 7.70%.
What is Jung Choi's role in Global Blood Therapeutics?
Jung Choi's role in Global Blood Therapeutics is Chief Business and Strategy Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.